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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYCRISPR-Cas9 gene editing of human cells and tissues holds much promise to advance medicine and biology, but standard editing
methods require weeks to months of reagent preparation and selection where much or all of the initial edited samples are destroyed dur-
ing analysis. ArrayEdit, a simple approach utilizing surface-modified multiwell plates containing one-pot transcribed single-guide RNAs,
separates thousands of edited cell populations for automated, live, high-content imaging and analysis. The approach lowers the time and
cost of gene editing and produces edited human embryonic stem cells at high efficiencies. Edited genes can be expressed in both plurip-
otent stem cells and differentiated cells. This preclinical platform adds important capabilities to observe editing and selection in situ
within complex structures generated by human cells, ultimately enabling optical and other molecular perturbations in the editing work-
flow that could refine the specificity and versatility of gene editing.INTRODUCTION
CRISPR-Cas9, an emerging genome surgery tool, exploits
an engineered ribonucleoprotein complex consisting of
two essential components: (1) a protein, Cas9; and (2) a sin-
gle-guide RNA (sgRNA). Together, theCas9-sgRNA complex
cuts a specific target sequence in the genome. Human cells
and tissues edited by CRISPR-Cas9 are important resources
for drug target identification (Kasap et al., 2014; Shi et al.,
2015; Smurnyy et al., 2014), regulatory science (Hsu
et al., 2014), medicine (Doudna, 2015), and basic biology
(Hsu et al., 2014; Sternberg and Doudna, 2015). However,
human gene-editing experiments frequently require labo-
rious cloning of expression plasmids for each sgRNA, and
there are limited opportunities in these culture systems to
watch and perturb genome surgery in action, as it is diffi-
cult to isolate and image living mutant cells during and
shortly after the DNA cleavage event. Overall, there is a
need to expand the throughput and capabilities of current
in vitro human culture systems where novel genome sur-
gery approaches can be evaluated with human cells and tis-
sues (Baltimore et al., 2015). Advanced capabilities with
human pluripotent stem cells in particular could eventu-
ally expand the suite of human preclinical model systems,
ranging from patient-specific cell lines to complex human
embryonic tissues established from stem cells.
Current gene-editing techniques generate heterogeneous
human cell populations that require significant subsequent
characterization. It is crucial to analyze the genome of
the edited cells by sequencing before continuing with
other studies, and several protocols require destruction ofStem Cemutant cell populations during sequencing analysis
(Ding et al., 2013; Kasap et al., 2014; Mali et al., 2013;
Miyaoka et al., 2014; Shi et al., 2015; Smurnyy et al.,
2014; Yang et al., 2013). For example, targeted gene disrup-
tion followed by selection and next-generation sequencing
can identify drug targets, but a separate, subsequent gene-
editing experiment is required to obtain livingmutant cells
for downstream analysis (Kasap et al., 2014; Sanjana et al.,
2014; Shalem et al., 2014; Shi et al., 2015; Smurnyy et al.,
2014; Wang et al., 2014), a process that is often infeasible
for slowly dividing or primary cells. This slows epigenomic
and functional characterization of properly edited cells,
and it is currently unknown whether there are persistent
epigenomic and functional problems within the edited
cells (Bosley et al., 2015). Further sequence-level character-
ization is also required at the single clone level, as there is
frequent and variable disruption of, or insertion of donor
DNA into, the non-targeted allele in edited cell lines (Mer-
kle et al., 2015). Finally, efficiencies of isolating precisely
edited cells remain a challenge with current methods, typi-
cally with 20% or lower efficiencies to make near-precise
deletions in the human genome (Byrne et al., 2015).
Here, we describe a platform, termed ArrayEdit, that com-
bines twocapabilities: one-pot transcription,andthecombi-
nation of microcontact printed plates and high content
analysis (HCA). First, we describe a method that can
generate many sgRNAs in parallel, within hours, using
chemically synthesized oligonucleotides ordered in amulti-
well format. One-pot transcribed sgRNAs can be delivered
without purification and can efficiently generate desired
gene edits within human embryonic stem cells (hESCs)ll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 109
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Figure 1. ArrayEdit: an Arrayed, High-
Content Platform to Monitor and Isolate
Gene-Edited Cells via One-Pot Tran-
scribed Single-Guide RNAs
(A) Overview of ArrayEdit assembly and key
components. Top: Schematic of one-pot PCR
and T7 transcription. All components can be
mixed and reacted within a single well
without any intermediate purification steps.
Primers are synthesized as custom oligonu-
cleotides. The forward primer defines the
genomic target of editing by Cas9. Bottom:
Surface modification to the bottom of
multiwell plates generates cell-adhesive
mFeatures on a glass bottom. Each mFeature
can be tracked over time via high-content
imaging and stitched together to form a
time-lapse visualization of edited cell phe-
notypes.
(B) Amount of sgRNA produced within each
well via one-pot transcription. Data are
represented as means ± 95% CI from four
independent one-pot transcriptions on each
sgRNA target (targets 1–3, mCherry-1-3;
4–6, GFP-1-3) and are not significantly
different (Student’s t-test, p > 0.05, Bon-
ferroni correction).
(C) RNA Bioanalyzer spectra of one-pot
transcribed sgRNA. Narrow peak (arrow-
head) is consistent with only the desired
product being produced. The reference peak
is used by the Bioanalyzer to standardize
size measurements.
(D and E) Flow cytometry histograms of HEK-H2B-mCherry cells (D) and WA09-H2B-mCherry hESCs (E) 4 days after delivery of mCherry-1
sgRNAs. sgRNA was either expressed of a plasmid, ordered commercially (U6-gBlock), created using previously described methods
(Gonzalez), or one-pot transcribed (n = 2; independent experiments). Sorted: a GFP plasmid is co-electroporated and then sorted for GFP+
cells, leading to enrichment of cells that contained exogenous nucleic acids. See also Figure S1 and Tables S1 and S2.whenco-deliveredwithCas9. Second,wedescribe a versatile
combination of culture and imaging to select edited cells
and tissues using non-destructive analysis of thousands of
spatially defined features that localize edited cell colonies/
aggregates. We were able to isolate gene-edited hESC lines
within 2 weeks, 82% of which were mutant for our desired
edit at aproof-of-concept locus (LAMA5)withoutanydetect-
able off-target mutations. This platform adds important ca-
pabilities to easily observe editing and selection in situ
within complex structures generated by human cells.RESULTS
Simplified One-Pot Transcription of sgRNAs in
Multiwell Plates
One key feature of ArrayEdit is the generation of one-pot
transcribed sgRNAs with chemically synthesized oligonu-110 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Autcleotides within a multiwell format. One-pot transcription
is similar to one-pot synthesis in chemistry, because prod-
ucts of the reaction are created at high yields without any
intermediate purification steps. As outlined in Figure 1A,
our method consists of three components: (1) a forward
primer containing a minimal T7 primer, sgRNA target
sequence, and a region for PCR amplification; (2) a dou-
ble-stranded sequence of DNA encoding the sgRNA
conserved region; and (3) a universal reverse primer for
PCR amplification (see Figure S1A and Tables S1 and S2
for sequences). This method is versatile and can generate
any desired sgRNA within hours, regardless of sequence
complexity. In contrast to other methods (Gonza´lez et al.,
2014; Liang et al., 2015; Lin et al., 2014), this process is
modular, such that advances in the sgRNA backbone that
refine specificity or increase editing efficiency (Chen
et al., 2013; Shechner et al., 2015) do not necessitate recre-
ating entire sgRNA libraries. All primers can be chemicallyhors
synthesized and delivered from commercial vendors
overnight, decreasing the time between design and
experiments.
To demonstrate the multiplexed synthesis of sgRNAs, we
designed six sgRNAs targeting two genes (mCherry,GFP; Ta-
ble S2) and ordered four replicates of each primer set in a
96-well format for subsequent one-pot transcription.
Next, PCR amplification was performed yielding a DNA
product that was of consistent size and concentration
across all targets (Figure S1B). These DNA products are reus-
able and can be stored for months, or used immediately for
in vitro transcription (IVT) with T7 RNA polymerase. IVT
was allowed to proceed for as little as 2 hr to overnight.
Longer incubation times resulted in increased concentra-
tion without any undesired products or degradation of
the sgRNA. When allowed to progress overnight, IVT
consistently produced greater than 90 mg of sgRNA in a
20-ml reaction (Figure 1B), suggesting that the concentra-
tion of rNTPs is the limiting reagent. With consistent
yields, this strategy renders post-production purification
or quantification unnecessary and allows us to use approx-
imate molar quantities of sgRNA during transfection
directly following IVT. This method of production also reli-
ably produces only the desired product of the correct size as
seen in a lone narrow peak when profiled by an RNA Bio-
analyzer 2100 (Figure 1C).
We designed and created one-pot sgRNAs to target 74
additional loci (Table S2) in both hESCs and human embry-
onic kidney (HEK) cells. After transfecting these sgRNAs
into cells, we determined the percent gene modification
in an EGFP transgene via flow cytometry (Figure S1C) and
in endogenous FGFR2 via restriction fragment-length poly-
morphism on genomic DNA (Figure S1D). Further, we de-
tected large-scale genome deletions in MUC16 and DPH7
using gel electrophoresis on genomic DNA (Figures S1E
and S1F). Large-scale genome deletions were created by
transfecting cells with two sgRNAs that are located 200–
4,000 bp apart from each other in the genome. A standard
agarose gel was then able to resolve if the sequence between
the two sgRNAs was deleted based on amplicon size. In all
cases, each one-pot sgRNA was capable of creating a tar-
geted DNA double-strand break that was likely resolved us-
ing non-homologous end-joining (NHEJ).
Next, we compared the gene-editing efficiency of one-
pot transcribed sgRNAs against the established methods
of sgRNA production. To quantify single-cell editing effi-
ciency, we used flow cytometry in conjunction with a
transgenic HEK-H2B-mCherry line, which was engineered
to constitutively express a fusion protein of histone 2B
(H2B) and mCherry from a single AAVS1 safe-harbor locus
(Figure S1G). sgRNAs were produced via one-pot transcrip-
tion, plasmid transfection (Mali et al., 2013), commercially
(termed a U6-gBlock), and via previously described IVTStem Cemethods (Gonza´lez et al., 2014). One-pot transcribed
sgRNAs resulted in the highest percentage of fluorescence
expression loss, successfully knocking out expression in
61% of cells (Figures 1D and 1E). In addition, one-pot
sgRNA production was the quickest method, requiring
only 2 days from design to experiment, whereas commer-
cially produced sgRNAs required 4–5 business days and pre-
viously described methods required a cloning step and
plasmid production scale-up (4 days). We then used
one-pot transcribed sgRNAs with a transgenic hESC line:
WA09-H2B-mCherry (Harkness et al., 2015). When one-
pot transcribed sgRNAs targeting mCherry were introduced
via electroporation into this line, some hESCs lostmCherry
expression after 4 days of culture. In addition, one-pot tran-
scribed sgRNAs generated five times more mCherry-nega-
tive cells when analyzed by flow cytometry than standard
techniques that express the same sgRNAs from plasmids
(Mali et al., 2013) (Figure 1E). One-pot transcribed sgRNAs
also performed nearly as well as methods that enrich for
transfected cells (Ding et al., 2013) via fluorescence-acti-
vated cell sorting (FACS) for GFP in a co-transfection with
a GFP-expressing plasmid.
Deep Sequencing of Edited Stem Cell Derivatives
To gain a more detailed analysis of genome-editing events
in hESCs and their matured cell derivatives, we performed
deep sequencing of cells edited by one-pot transcribed
sgRNAs.We first generated one-pot transcribed sgRNAs tar-
geting seven genes that mark pluripotent, ectodermal,
mesodermal, and endodermal cells. These one-pot sgRNAs
were electroporated into a HUES8 hESC line with an induc-
ible Cas9 transgene (Gonza´lez et al., 2014). The electropo-
rated hESCs were cultured for several passages and then
matured into embryoid bodies (EBs) for 5 days to allow cells
to differentiate into all three germ layers. mRNA was ex-
tracted from the EBs and reverse transcribed into cDNA.
PCR using primers flanking each of the sgRNA target sites
was performed and prepared for sequencing via Illumina
Hi-Seq.We found 20%–92% of reads overlapping the target
sites contained at least one insertion or deletion (indel)
within a 100-nucleotide window around the expected
cut site (Figure 2A). Consistent with NHEJ repair at the ex-
pected cut site, both frameshift and in-frame indels were
observed for all of these loci (Figure 2A, gray, orange). We
also observed that many more reads with an indel con-
tained a deletion event (85%) than contained an insertion
event (15%) (Figure 2B). Similar observations were reported
in deep sequencing analysis of human cells edited by
S. pyogenes Cas9 (Mali et al., 2013; Schumann et al., 2015).
The sequencing results allowed quantitative analysis of
observed indel mutations and their spatial distribution in
the target region. The results in Figure 2C show the fre-
quency of indels in the endodermal markers, CDH20 andll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 111
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Figure 2. Deep Sequencing Reveals High-
Efficiency Modification by One-Pot Tran-
scribed sgRNAs
(A) Fraction of sequencing reads from gene-
edited, hESC-derived embryoid bodies that
matched the wild-type (WT) sequence
(blue), contained at least one insertion or
deletion (indel, orange), or contained an in-
frame indel (gray). Edits occurred in genes
and transcripts marking all three germs
layers (ectoderm [PAX6, POU4F1], meso-
derm [CDH5], endoderm [CDH20, FOXP2])
and pluripotent stem cells (NANOG, OCT4).
Total: all reads across the seven loci.
(B) Frequency of insertion events to dele-
tion events in the sequencing reads, with
deletion being 53 more common than
insertion.
(C) Per base frequency of matches to the
wild-type sequence for three genes (CDH20,
FOXP2, PAX6). Red bases denote the sgRNA
target sequence while blue bases denote
the protospacer adjacent motif (PAM). Red
arrows indicate the predicted site of double-
strand break formation by Cas9. The begin-
ning and ending sequences (17–22 bp) for
each gene are uniform, because they
contain reads that were amplified using
primers (17–22 bp) during PCR.FOXP2, and an ectodermal marker, PAX6. In EBs derived
from edited cells, we found the highest frequency of indels
three to four nucleotides upstream from the protospacer
adjacent motif (PAM) sequence (Figure 2C), consistent
with reports of type II CRISPR systems. Taken together,
one-pot sgRNAs, when combined with Cas9, can generate
targeted genomic edits in hESCs that can be expressed in
differentiated cells.
Patterning Adhesive Microfeatures to Separate Gene-
Edited hESCs
In previous experiments, all gene-edited cells within stan-
dard cell culture were interspersed with wild-type cells, so112 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Autcolonies would need to be selected, dissociated, and subcl-
oned to isolate gene-edited cells for subsequent culture
and analysis. Such a mixture can be easily visualized in
the mCherry-edited cells (Figure S1H). To overcome labo-
rious downstream clonal selection steps in the editing
workflow, we designed our ArrayEdit platform to separate
edited cells by exploiting microcontact printing (mCP) on
the surface of multiwell plates. mCP was performed on
gold-coated glass (Harkness et al., 2015) to create surfaces
within standard culture multiwell plates that contained
greater than 400 circular mFeatures of 300 mm diameter
per well, allowing for the spatially controlled growth
of up to 2,400 separate gene-edited cells per standardhors
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Figure 3. Substrate Micropatterning En-
ables Live HCA of Gene Editing
(A) Isolation of homogeneous mCherry
gene-edited hESC lines on micropatterned
plates. Clonal knockouts can be reliably
identified and expanded in spatial isolation
on each mFeature.
(B) Sanger sequencing of mCherry-edited
clones isolated via ArrayEdit. The sgRNA
target is denoted in red and the protospacer
adjacent motif (PAM) in blue. Deletions are
represented in yellow and the total length of
deletion is to the right of the sequence
(e.g., D76 indicates a deletion of 76 base
pairs).
(C) High-content image acquisition
and analysis workflow. Images are taken in a
20 3 20 grid and are passed to CellProfiler.
Different colors indicate distinct identified
objects (nuclei). CellProfiler results are sent
to a MySQL database.
(D) Image of ArrayEdit within one standard
culture well. Each mFeature can be tracked
over time and stitched together to form a
time-lapse visualization of edited cell phe-
notypes. Clones in two separate features are
shown on days 4, 5, and 6.
(E) Growth curves for cells within
24 mFeatures on ArrayEdit over 5 consecu-
tive days after editing with LAMA5 sgRNAs.
Curves were separated into high- and low-
growth rate groups. See also Table S3.6-well tissue culture plate (Figure S2A). The poly(ethylene
glycol) (PEG) brush surface layer after mCP does not
contain defects common to other stamped PEG surfaces,
and mFeatures are stable upon extended culture for over
30 days (Sha et al., 2013).
ArrayEdit enabled the facile isolation of living gene-edi-
ted hESCs. We electroporated one-pot transcribed sgRNAs
against mCherry into our WA09-H2B-mCherry labeled
line along with a plasmid encoding Cas9. Cells were then
seeded at clonal density on ArrayEdit according to a Pois-
son distribution, such that there would be high probability
for 0 or 1 cell to be within each mFeature. Four days after
transfection, it was trivial to identify WA09-H2B-mCherry
clones of interest via fluorescent microscopy (Figure 3A).
We then randomly selected four clones that lost fluores-
cence and transferred them to separate wells of a 24-well
plate. After 5 days of subsequent culture, genomic DNAStem Cewas harvested and Sanger sequenced across the expected
sgRNA target site. The sequences revealed indel mutations
at the desired target causing loss of mCherry fluorescence
(Figure 3B). Interestingly, two of the clones isolated
possessed the same modification, suggesting the presence
of local DNAmicrohomology influencingDNA repair path-
ways (Bae et al., 2014).
HCA to Identify Properly Edited hESCs
To enablemarker-less identification of gene-edited cells, we
developed an automated high-throughput HCA within
ArrayEdit (Figure 3C). Twenty-four hours post-seeding
and at each subsequent 24 hr, fluorescence microscopy
was used to individually image each mFeature. Due to the
array-based format and spatial control of the mFeatures,
daily images can be used to create a time-lapse image
of cell number within each mFeature (Figure 3D). Anll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 113
automated analysis pipeline to assess cell number was
created in CellProfiler (Carpenter et al., 2006), a software
package for image analysis. From the image, the number
of nuclei per image was identified (Figure S2B) and written
to a database for further analysis (Supplemental Text). Us-
ing high-throughput computing, 15,000 images can be
analyzed in the span of a few hours. Data from individual
mFeatures over multiple days were joined together to pro-
vide the growth rate for cells within each mFeature (see
example in Figures 3E, S2C, and S2D).
We sought to test the speed and efficiency of ArrayEdit
against prior work on LAMA5, because specific domains
of LAMA5 gene edits are predicted to render a selectable
phenotype in several culture conditions (Laperle et al.,
2015). a-5 laminin, encoded by LAMA5, is an extracellular
matrix protein recently identified as an autocrine/para-
crine factor regulating self-renewal of hESCs (Laperle
et al., 2015). Isolating growth-deficient LAMA5mutants us-
ing standard gene editing to study the function of this fac-
tor is difficult in standard cultures, as they are quickly out
competed by unwanted wild-type cells. In prior work (La-
perle et al., 2015), through FACS followed by laborious sub-
cloning of 50 gene-edited colonies, we isolated only a few
lines edited at LAMA5.
On ArrayEdit, three sgRNAs were designed that targeted
consecutive exons in the globular domains of the integrin
binding 30 region of LAMA5 (Figure 4A). One-pot tran-
scribed sgRNAs were electroporated as a pool such that
any cell that receives separate two sgRNAs can experience
a deletion on the order of 100s of base pairs via NHEJ repair,
which can disrupt LAMA5 function. Exploiting HCA over a
period of 6 days, we tracked 480 potential gene-edited
LAMA5 clones and observed clones that expanded rapidly
as well as clones that lagged behind (Table S3, Figure 3E).
Many clones followed an exponential growth model of
proliferation, suggesting that they had not been edited
and maintained a wild-type phenotype. However, there
was another population of clones exhibiting a non-stan-
dard growth phenotype, suggesting that increased rates of
apoptosis or decreased rates of self-renewal may be due to
LAMA5 edits. We manually separated the clones into three
different categories: low, intermediate, and high growth
(Figures 3E, S3A, and S3B). Comparison of cell number
per mFeature as well as doubling times between the high-
and low-growth population revealed a significant differ-
ence between the populations (Student’s two-tailed t test,
p < 5 3 105) despite large variations in the slow-growth
population (Figures S3B and S3C). The exact mFeature on
ArrayEdit corresponding to the growth profile was identi-
fied using HCA, andwewere able to easily pick clones of in-
terest for expansion and further analysis. Twelve clones
were isolated and expanded from each of the high- and
intermediate-growth populations, and subsequently sub-114 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Autjected to Sanger sequencing. As expected, all the high-
growth clones maintained a wild-type genotype at all three
sgRNA cut sites (Figures S3D and S3E, data not shown). All
the intermediate-growth clones also sequenced correctly at
all three loci, and expanded in a manner similar to high-
growth populations after isolation, suggesting that there
is some modest post-transfection transient variability in
the growth rate of clones (Figures S3A and S3E). Therefore,
we proceeded to focus our analysis on clones from the low-
growth population.
We isolated, expanded, and genotyped low-growth
clones identified by HCA on ArrayEdit for further charac-
terization. The deletions generated by the sgRNA pool
within hESC lines can easily be resolved on a standard
agarose gel (Figure 4B). Agarose gels are intended as a
semi-quantitative measure that can quickly screen clones
to identify alleles that have undergone large-scale dele-
tions. Due to differential repair pathways in edited cells
such as microhomology-mediated end-joining (Bae
et al., 2014), this quick assay may contain variable band
sizes, and products require follow-on sequencing to
confirm that the exact modification has occurred. Regard-
less, this gel assay was used to reveal cells that have been
cut by two sgRNAs, producing either single or biallelic de-
letions. Agarose gels of isolated clones revealed 82% of
clones had at least one large-scale deletion in the
LAMA5 allele (Figures 4C, 4D, and S3E). Of all selected
clones, 46% contained a single allele edit, and 36% con-
tained a biallelic edit, although not necessarily homozy-
gous. The remaining 18% harbored wild-type genotypes,
as determined by agarose gel screening assay. For the three
sgRNAs transfected, three different large-scale deletions
are predicted, all of which were observed (Figures S4A
and S4B) suggesting that all sgRNAs within ArrayEdit
were effective in cleaving genomic targets at similar rates.
These results demonstrate significant improvement over
prior methods used to obtain LAMA5 gene-edited hESCs,
where sequencing over 50 clones isolated via standard
FACS methods yielded only one single allelic mutant
and no biallelic modifications (Laperle et al., 2015)
(Figure 4D).
On ArrayEdit, we selected five clones that exhibited a
biallelic mutation pattern on the agarose screening gel for
further analysis via sequencing. Of these five lines, three
clones were found to contain near-precise, homozygous
deletions between two sgRNAs (Figure 4E). The remaining
two clones contained complex deletions around the sgRNA
targets (Figure 4F). These lines were further subjected to off-
target analysis as they are themost likely to have contained
functional Cas9-sgRNA complexes and are therefore most
likely to have experienced off-target activity. Off-target
analysis on all five selected cell lines was performed by
Sanger sequencing at three loci predicted by bioinformaticshors
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Figure 4. Genetic Characterization of
hESC Clones Isolated from ArrayEdit
(A) Schematic of CRISPR-targeted regions
in LAMA5 including the primers used for
genomic amplification.
(B) Agarose gel of PCR products generated
from amplification of genomic DNA iso-
lated from an ArrayEdit gene-deleted
clone. Gel indicates the expected deletions
spanning hundreds of base pairs. Single
allele mutants can be identified by the
presence of a wild-type (WT) length band,
while biallelic mutants are identified by
the absence of a wild-type band.
(C) Agarose gel of PCR products generated
from amplification of genomic DNA isolated
from ArrayEdit gene-edited hESC lines.
ArrayEdit was implemented on hESCs with
three sgRNAs targeting LAMA5 as shown in
(A) Gel indicates the expected deletions
spanning hundreds of base pairs. Red clone
names denote single allele edited lines,
while green denotes biallelic modifica-
tions. Each allele is denoted by a colored
asterisk corresponding to which sgRNA
combination is presumed to have made the
modification. Underlined clones are repre-
sentative clones presented in the main
text.
(D) Summary of genotypes obtained from
hESC lines isolated after gene editing using
ArrayEdit or standard procedures (see text).
Efficiencies of generating edited cells are
significantly higher on ArrayEdit. Genotypes
are detailed in (C).
(E) Sanger sequencing analysis of repre-
sentative biallelic edited hESC lines
chosen in (C) that displayed gene editing
between two sgRNAs. Wild-type is denoted
on top, and the biallelic edited hESCs are
below. Color codes are the same as in Figure 3. Non-faithful nucleotides in sequence alignment are in gray and are believed to be
caused by 1 or 2 bp differences in alleles, causing misreads during sequencing.
(F) Sanger sequencing analysis of representative biallelic edited hESC lines chosen in (C) that displayed unexpected deletions around one
sgRNA site (A10) or potential differing modifications to both alleles (G10).
(G) The sequence around the top potential off-target site for Cas9 with sgRNA1 is shown at the bottom. No modifications were observed in
the sequencing results from any of the edited hESC clones. See also Figures S3 and S4.analysis (Hsu et al., 2013) to be the most likely off-target
sites. This methodology does not preclude the possibility
that there are other, unpredicted, gene edits. However,
whole-genome sequencing would be required to find these
modifications and was not pursued in this work.
Sequencing at the most likely off-target loci revealed per-
fect alignment with the reference genotype in all five iso-
lated biallelic clones, indicating that ArrayEdit can be
used to generate targeted edits with minimal off-target
effects (Figures 4G and S4C).Stem CePhenotypic Characterization of LAMA5-Edited hESCs
The five selected biallelic LAMA5 gene-edited hESC lines
were subsequently cultured on commonly used culture
substrates: matrigel and laminin-111, both of which sup-
ply a low level of exogenous a-5 laminin but are insuffi-
cient to rescue the complete growth phenotype (Laperle
et al., 2015). Importantly, all of the isolated clones ex-
pressed high levels of pluripotency markers, indicating
that use of ArrayEdit does not lead to differentiation
(Figure S5).ll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 115
Figure 5. ArrayEdit Rapidly Produces Living, Well-Characterized, and Functional LAMA5 Gene-Edited hESC Lines
(A) Representative images of hESC colony formation of each biallelic edited line on both matrigel- and laminin111-coated substrates.
Laminin-111 contains less matrix proteins thereby accentuating self-renewal defects generated from loss of a-5 laminin protein domains
in the biallelic edited cells. Clone G10 notably displayed a drastic decrease in cell number on laminin-111. WT, wild-type.
(B) Detection of apoptosis levels by immunocytochemistry of cleaved caspase-3. Each biallelic clone had detectable apoptotic cells (some
are denoted by arrowheads). All scale bars represent 100 mm.
(C and D) Mean number of cells (C) and cleaved caspase-3 positive cells (D) ±1 SD for each hESC clone on matrigel, laminin-111, laminin-
521 coated substrates after 4 days in culture on various substrates as determined by flow cytometry (n = 4; independent experiments). On
matrigel and laminin-111 substrates, each biallelic edited line was less dense than wild-type cells (Student’s two-tailed t test, p < 0.05),
indicating a functional defect in self-renewal. On laminin-521 substrates, each clone was at least as dense as wild-type cells, and had a
similar number of apoptotic cells as wild-type except for G10. This may be due to complex deletions in the G10 clone. Clone G10 could not
be detected (n.d.) due to a low cell number on laminin-111. Clone C8 had an in-frame mutation that may be partially rescued on the
matrigel substrate and had a significantly higher number of cells on laminin-521.
(E) Comparison of ArrayEdit against standard methods to produce gene-edited cells. ArrayEdit is approximately 23 faster and produces
significantly more gene-edited cell lines (see Figure 4D). ArrayEdit reduces or eliminates several steps in the gene-editing workflow and
additionally has important multiplexing and HCA capabilities. See also Figure S5.After 3 days of culture, all five biallelic edited clones had
significantly less cell numbers than the wild-type cells
(n = 4; Student’s two-tailed t test, p < 0.05) (Figures 5A
and 5C) on both matrigel and laminin-111 substrates. All
five clones had increased levels of apoptosis on laminin-
111 compared with wild-type cells, while four of the five
clones had higher levels of apoptosis onmatrigel compared116 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Autwith wild-type (Figures 5B and 5D). Comparison of specific
mutation to cell growth rate revealed that the clone with
the earliest predicted stop codon in a-5 laminin, G10,
with complex frameshift edits from exon 66 onward, had
the least number of cells (Figure 5C) and among the highest
levels of apoptosis (Figure 5D), while the clone with the
latest predicted stop codon in a-5 laminin, C8, with onlyhors
an in-frame deletion between exons 67 and 68, had levels
of apoptosis similar to wild-type levels on matrigel (Fig-
ure 5D). The longer a-5 laminin produced by clone C8
may come together with an important component of ma-
trigel to rescue apoptotic cells.
We then cultured all five LAMA5 gene-edited lines on
laminin-521, which has been proven to rescue growth
phenotype in LAMA5 knockouts (Laperle et al., 2015), to
show that growth phenotype differences are a direct cause
of the biallelic knockout. After 3 days in culture, four of the
five lines had similar cell numbers to the wild-type, while
one, C8, had a larger cell number (Figure 5C). Four of five
clones also had levels of apoptosis, measured by cleaved
caspase-3 percentage, similar to the wild-type cells. Clone
G10, with its complex frameshift and early stop codon,
had a slightly elevated percentage of apoptotic cells
(Figure 5D).
Overall, these results indicate that LAMA5 gene-edited
cells on ArrayEdit exhibit the expected phenotype (Laperle
et al., 2015), involving decreased rates of proliferation,
high rates of apoptosis (Figures 5C and 5D), or a combina-
tion of both, on both matrigel and laminin-111. This
phenotype was fully rescued by supplying a source of exog-
enous laminin-521, supporting the conclusion that precise
edits were the only cause of the phenotype. ArrayEdit for
LAMA5 took approximately 15 days from conception and
design to clonal expansion, which is substantially faster
than the state-of-the-art methods that can take upward of
a month (Figure 5E).DISCUSSION
Here we tested whether a combination of improvements to
the gene-editing workflow for hESCs would increase the ef-
ficiency and throughput of the overall process. One-pot
transcription combined with mCP plates and HCA
increased the multiplexing of edits within a single well or
multiwell plate (three sgRNAs with three sgRNA combina-
tions), increased the efficiency of isolating edited clones
to 82%, and reduced the time necessary for a complete
gene-editing workflow (15 days versus >30 days). To our
knowledge, no other platform has combined these capabil-
ities to gene edit cell lines. This combination of capabilities
is most powerful when edited cells have phenotypes that
can be distinguished with HCA. Lists of genes and sgRNA
targets are now being assembled across pooled growth se-
lection screens (Xu et al., 2015), and customized cells edi-
ted at many of these targets could be readily generated on
ArrayEdit.
ArrayEdit is capable of identifying potentially edited cells
by HCA in a non-destructive manner without single-cell
dissociation or added transgenes, in contrast to FACS andStem Cesequencing-based methods to identify edited cells. This
capability permits longitudinal temporal tracking of phe-
notypes within cells, with subcellular resolution, and
avoids the need for subcloning, which typically adds at
least 3–7 days to the workflow. ArrayEdit thus significantly
reduces the culture and passaging required to isolate edited
cells, enabling gene editing in human cell types that
undergo substantial phenotypic changes with prolonged
culture or primary cells that can only be cultured for few
passages prior to senescence. In addition, ArrayEdit allows
for the continuous culture of mutants that experience a
deficit in self-renewal due to gene edits and would be out
competed in standard culture. We found that 36% of our
edited clones harbored biallelic editing of LAMA5, which
is comparable with other CRISPR-Cas9 studies in human
pluripotent stem cells (D’Astolfo et al., 2015; Ding et al.,
2013; Gonza´lez et al., 2014; Mali et al., 2013). Efficiencies
of editing on ArrayEdit would likely increase with advances
in delivery modalities of DNA, RNA, and protein
(Chiappini et al., 2015; D’Astolfo et al., 2015; Zuris et al.,
2015) and application of additional selection pressure,
such as drug selection (e.g., D’Astolfo et al., 2015; Merkle
et al., 2015). The 82% efficiency that we demonstrate on
ArrayEdit is below the 95%–100% purity of isolating edited
cell lines by FACS frequently followed by drug selection,
but our platform facilitates the identification of pheno-
types by HCA, phenotypes that are very difficult or impos-
sible to track with FACS. Furthermore, sorting can cause
cellular stress, increasing cell death, which is especially
challenging when isolating edited cells with a growth
defect.
While we only implemented ArrayEdit for fluorescence
loss and growth rate differences, the method employing
HCA is extendable in principle to any image-based pheno-
type. Phenotypes could be defined by changes in uptake of
cytoxicity dyes, live immunocytochemistry for cell surface
or extracellular matrix markers, calcium flux dyes, or mito-
chondrial functional dyes (Taylor and Haskins, 2007).
A distinguishable phenotype in edited cells may not be
readily apparent by HCA in the pluripotent stem cell state.
Hence, differentiation on ArrayEdit may be required to
distinguish edited phenotypes. These capabilities on
ArrayEdit seem possible, as arrayed neural organoid culture
has already been achieved on mCP plates (Knight et al.,
2015). More sophisticated computational methods could
be easily implemented in our analysis pipeline in CellPro-
filer to prospectively identify imaging phenotypes that
connect to proper or abnormal biological and epigenomic
characteristics of edited cells (Singh et al., 2014). Because
all edited clones share the same culture medium, the
intra-well benchmarking of phenotypes onArrayEdit could
enable identification of phenotypes that may be lost due to
noise or fluctuations in medium composition amongll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 117
culture wells or plates. Variations in signaling factors in the
medium could also lead to hESC clones that become more
or less lineage committed (Nazareth et al., 2013), opening a
window to study the biological variability within clones
that is difficult to ascertain during standard genotyping
of clones. The stringent definition of phenotypes enabled
by HCA with ArrayEdit will likely permit a more thorough
characterization of the biological and functional conse-
quences of various gene-editing protocols.
Current limitations of ArrayEdit arise from setting up the
platform and screening for phenotypes in pluripotent cells.
Although mCP is a straightforward technique, ArrayEdit is
not a turn-key ready platform for many traditional biology
or industrial laboratories who may need access to laser cut-
ting or automated microscopy units. However, many com-
mercial HCA instruments are available on the market, and
our HCA pipeline can be readily employed using standard
cloud-based computing or even a personal computer. The
simple, versatile, and well-characterized mCP chemistry re-
quires only standard laboratory equipment. The chemistry
could also be flexibly modified to create various hydrophil-
ic and hydrophobic areas on a single surface (McNulty
et al., 2014; Sha et al., 2013), even well-of-the-well, water-
in-oil culture platforms that are routinely used in pre-im-
plantation embryo culture. Such chemically defined
surfaces may be particularly attractive for clinical applica-
tion in future work.
One-pot transcription of sgRNAs from PCR amplicons
generated by oligonucleotide DNA primers produced clean
and functional sgRNAs. One-pot transcribed sgRNAs can be
rapidly designed andmade from commercial vendors over-
night with costs scaling with 20–60 base pair synthesis;
the costs are anticipated to decrease over time (currently
<$1 USD per sgRNA per experiment; see Table S4). In
contrast to othermethods that require the purchase ofmul-
tiple oligonucleotides, our method requires only one
unique oligonucleotide that can be synthesized in a multi-
well plate format by commercial vendors, decreasing the
setup time and the possibility of pipetting error. Errors in
long (>60 nt), chemically synthesized oligonucleotides
(up to 10%) have been observed (Liang et al., 2015), and
our method notably avoids the use of long oligonucleo-
tides by using a sequence-verified, synthesized, double-
stranded DNA for the long universal region of the sgRNA.
Our modular design also permits facile incorporation of
additional RNA elements and devices (Nissim et al., 2014;
Shechner et al., 2015). Furthermore, our method per-
formed better than several previously described methods
(Gonza´lez et al., 2014; Mali et al., 2013) (Figures 1D
and E) and generated sgRNAs in less than 2 days. When
analyzed via deep sequencing, one-pot sgRNAs had an effi-
ciency of editing between 20% and 92% of mRNA tran-
scripts after EB differentiation. Interestingly, many of the118 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Auttranscripts analyzed (5 of 7) had a higher percentage of
in-frame mutations than would be caused by random
chance (33%) (Shi et al., 2015). This may suggest that there
were selection pressures in the EB cultures that modify the
mutation spectrum observed.
We observed no off-target mutations in our edited cell
lines at eight bioinformatically predicted sites by using
one-pot sgRNAs, although we cannot rule out the presence
of mutations at other loci. Because optimized Cas9 mRNA
and protein delivery can reduce off-target mutagenesis
(Kim et al., 2014), one-pot transcribed sgRNAs could be
combined with these methods of delivering Cas9 to reduce
the risk of off-target mutagenesis.
Overall, ArrayEdit provides a window into the editing
process that could be useful in refining the specificity and
versatility of CRISPR-Cas9 gene-editing techniques. In
situ HCA could incorporate new optical and imaging tech-
niques that monitor and perturb CRISPR-Cas9 editing.
Inducible (Davis et al., 2015; Zetsche et al., 2015) and opti-
cal control (Hemphill et al., 2015; Nihongaki et al., 2015) of
Cas9 activity has been demonstrated, and various spatial
and temporal perturbations could be tested in future
work on ArrayEdit. New nucleic acid probes could also
visualize, or paint, specific loci of cells (Chen et al., 2013;
Ma et al., 2015) within complex cellular structures on
ArrayEdit, permitting the specific editing and isolation of
edited clones with enhanced precision. ArrayEdit is fully
compatible with existing screening platforms, so that
small-molecule or other biological screens could be tested
to enhance the efficacy of any desired gene-editing proto-
col. Also, ArrayEdit could be easily adapted to isolate cells
with appropriate phenotypes after application of engi-
neered, nuclease-dead, Cas9 protein fusions, such as those
designed to activate or repress gene transcription. Finally,
ArrayEdit will be likely applicable to many other human
cell types, providing an attractive route to generating
gene-edited human cells for a variety of industrial and pre-
clinical purposes.EXPERIMENTAL PROCEDURES
All work with human embryonic stem cell lines was carried out in
accordance with institutional, national, and international guide-
lines and approved by the Stem Cell Research Oversight Commit-
tee at the University of Wisconsin-Madison.One-Pot Transcription of sgRNAs
IVT sgRNAs were synthesized in parallel in a 96-well plate within
1 day. The first step employed PCR with two chemically synthe-
sized primers and a 125-bp double-stranded DNA template (Inte-
grated DNA Technologies; see Figure S1A). Forward primers were
ordered in 96-well plate format to enable high-throughput synthe-
sis. PCR was performed using Phusion High-Fidelity Polymerasehors
(New England Biolabs) according to the manufacturer’s protocols
and was placed in the thermocycler at 98C for 30 s followed by
35 cycles of 98C for 5 s, 52C for 10 s, and 72C for 15 s before
a final extension period of 72C for 10 min. A truncated T7
promoter was included in the forward primer, which allowed the
transcription of sgRNAs via a 37C overnight reaction with a
MEGAshortscript kit (Life Technologies).High-Content Image Acquisition and Analysis
Automated microscopy was performed using a Nikon Eclipse TI
epifluorescent microscope and NIS Elements Advanced Research
(V4.30) software. The ND acquisition 6D module was used to
establish a 20 3 20 grid pattern such that one 103 image was
taken at each mFeature and combined in a single file. Nikon Per-
fect Focus was used to ensure that all images were in the same
Z-plane and in focus. Each image was then corrected for illumina-
tion defects using CellProfiler (Carpenter et al., 2006) and the
number of nuclei was determined (Figure S2). Analysis was per-
formed in a massively parallel manner using the Center for
Throughput Computing (UW-Madison) and results were written
to a local MySQL database. MySQL Workbench 6.1 CE was used
to retrieve the data and join tables from time points on the basis
of well and position.ACCESSION NUMBERS
Raw reads from sequencing are available at NCBI Bioproject:
PRJNA304252 and upon request.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, Supplemental Text, five figures, and four tables and
can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2015.11.014.
AUTHOR CONTRIBUTIONS
J.C.S. and K.S. conceived and supervised the whole project. J.C.S.
performed the major part of the research and wrote the manu-
script with input from all authors. A.M., B.S., L.K., M.G., M.L.,
and R.P. provided technical support and comments on the
manuscript.
ACKNOWLEDGMENTS
We acknowledge support from the National Science Foundation
[CBET-1350178 to K.S.], NIH [NHGRI 5T32HG002760 and
T32GM008692-16 to B.S.] and the VitreoRetinal Surgery Founda-
tion [B.S.]. We thank plasmid depositors to Addgene, Huangfu
lab for sharing the iCRISPR lines, the University of Wisconsin
Biotechnology Center DNA Sequencing Facility, and T. Klann, H.
Yue, I. Linsmeier, and J. Saha for assistance with Cas9.
Received: June 19, 2015
Revised: November 27, 2015
Accepted: November 27, 2015
Published: January 12, 2016Stem CeREFERENCES
Bae, S., Kweon, J., Kim, H.S., and Kim, J.-S. (2014). Microhomol-
ogy-based choice of Cas9 nuclease target sites. Nat. Methods 11,
705–706.
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R.A.,
Church, G., Corn, J.E., Daley, G.Q., Doudna, J.A., Fenner, M.,
et al. (2015). A prudent path forward for genomic engineering
and germline gene modification. Science 348, 36–38.
Bosley, K.S., Botchan, M., Bredenoord, A.L., Carroll, D., Charo,
R.A., Charpentier, E., Cohen, R., Corn, J., Doudna, J., Feng, G.,
et al. (2015). CRISPR germline engineering—the community
speaks. Nat. Biotechnol. 33, 478–486.
Byrne, S.M., Ortiz, L., Mali, P., Aach, J., and Church, G.M. (2015).
Multi-kilobase homozygous targeted gene replacement in human
induced pluripotent stem cells. Nucleic Acids Res. 43, e21.
Carpenter, A.E., Jones, T.R., Lamprecht, M.R., Clarke, C., Kang,
I.H., Friman, O., Guertin, D.A., Chang, J.H., Lindquist, R.A., Mof-
fat, J., et al. (2006). CellProfiler: image analysis software for identi-
fying and quantifying cell phenotypes. Genome Biol. 7, R100.
Chen, B., Gilbert, L.A., Cimini, B.A., Schnitzbauer, J., Zhang,W., Li,
G.-W., Park, J., Blackburn, E.H., Weissman, J.S., Qi, L.S., and
Huang, B. (2013). Dynamic imaging of genomic loci in living hu-
man cells by an optimized CRISPR/Cas system. Cell 155, 1479–
1491.
Chiappini, C., De Rosa, E.,Martinez, J.O., Liu, X., Steele, J., Stevens,
M.M., and Tasciotti, E. (2015). Biodegradable silicon nanoneedles
delivering nucleic acids intracellularly induce localized in vivo
neovascularization. Nat. Mater. 14, 532–539.
D’Astolfo, D.S., Pagliero, R.J., Pras, A., Karthaus, W.R., Clevers, H.,
Prasad, V., Lebbink, R.J., Rehmann, H., andGeijsen, N. (2015). Effi-
cient intracellular delivery of native proteins. Cell 161, 674–690.
Davis, K.M., Pattanayak, V., Thompson, D.B., Zuris, J.A., and Liu,
D.R. (2015). Small molecule-triggered Cas9 protein with improved
genome-editing specificity. Nat. Chem. Biol. 11, 316–318.
Ding, Q., Regan, S.N., Xia, Y., Oostrom, L.A., Cowan, C.A., andMu-
sunuru, K. (2013). Enhanced efficiency of human pluripotent stem
cell genome editing through replacing TALENs with CRISPRs. Cell
Stem Cell 12, 393–394.
Doudna, J.A. (2015). Genomic engineering and the future of med-
icine. JAMA 313, 791–792.
Gonza´lez, F., Zhu, Z., Shi, Z.-D., Lelli, K., Verma, N., Li, Q.V., and
Huangfu, D. (2014). An iCRISPR platform for rapid, multiplexable,
and inducible genome editing in human pluripotent stem cells.
Cell Stem Cell 15, 215–226.
Harkness, T., McNulty, J.D., Prestil, R., Seymour, S.K., Klann, T.,
Murrell, M., Ashton, R.S., and Saha, K. (2015). High-content imag-
ing with micropatterned multiwell plates reveals influence of cell
geometry and cytoskeleton on chromatin dynamics. Biotechnol.
J. 10, 1555–1567.
Hemphill, J., Borchardt, E.K., Brown, K., Asokan, A., andDeiters, A.
(2015). Optical control of CRISPR/Cas9 gene editing. J. Am. Chem.
Soc. 137, 5642–5645.
Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S.,
Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. (2013).ll Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Authors 119
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Bio-
technol. 31, 827–832.
Hsu, P.D., Lander, E.S., and Zhang, F. (2014). Development and ap-
plications of CRISPR-Cas9 for genome engineering. Cell 157,
1262–1278.
Kasap, C., Elemento, O., and Kapoor, T.M. (2014). DrugTargetSeqR:
a genomics- and CRISPR-Cas9–based method to analyze drug tar-
gets. Nat. Chem. Biol. 10, 626–628.
Kim, S., Kim, D., Cho, S.W., Kim, J., and Kim, J.-S. (2014). Highly
efficient RNA-guided genome editing in human cells via delivery
of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012–1019.
Knight, G.T., Sha, J., and Ashton, R.S. (2015). Micropatterned,
clickable culture substrates enable in situ spatiotemporal control
of human PSC-derived neural tissue morphology. Chem. Com-
mun. (Camb). 51, 5238–5241.
Laperle, A., Hsiao, C., Lampe, M., Mortier, J., Saha, K., Palecek, S.P.,
and Masters, K.S. (2015). a-5 laminin synthesized by human
pluripotent stem cells promotes self-renewal. Stem Cell Rep. 5,
195–206.
Liang, X., Potter, J., Kumar, S., Zou, Y., Quintanilla, R., Sridharan,
M., Carte, J., Chen, W., Roark, N., Ranganathan, S., et al. (2015).
Rapid and highly efficient mammalian cell engineering via Cas9
protein transfection. J. Biotechnol. 208, 44–53.
Lin, S., Staahl, B.T., Alla, R.K., and Doudna, J.A. (2014). Enhanced
homology-directed human genome engineering by controlled
timing of CRISPR/Cas9 delivery. eLife 3, e04766.
Ma, H., Naseri, A., Reyes-Gutierrez, P., Wolfe, S.A., Zhang, S., and
Pederson, T. (2015). Multicolor CRISPR labeling of chromosomal
loci in human cells. Proc. Natl. Acad. Sci. USA 112, 3002–3007.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E.,
Norville, J.E., and Church, G.M. (2013). RNA-guided human
genome engineering via Cas9. Science 339, 823–826.
McNulty, J.D., Klann, T., Sha, J., Salick, M., Knight, G.T., Turng,
L.-S., and Ashton, R.S. (2014). High-precision roboticmicrocontact
printing (R-mCP) utilizing a vision guided selectively compliant ar-
ticulated robotic arm. Lab. Chip 14, 1923–1930.
Merkle, F.T., Neuhausser, W.M., Santos, D., Valen, E., Gagnon, J.A.,
Maas, K., Sandoe, J., Schier, A.F., and Eggan, K. (2015). Efficient
CRISPR-Cas9-mediated generation of knockin human pluripotent
stem cells lacking undesired mutations at the targeted locus. Cell
Rep. 11, 875–883.
Miyaoka, Y., Chan, A.H., Judge, L.M., Yoo, J., Huang, M., Nguyen,
T.D., Lizarraga, P.P., So, P.-L., and Conklin, B.R. (2014). Isolation of
single-base genome-edited human iPS cells without antibiotic se-
lection. Nat. Methods 11, 291–293.
Nazareth, E.J.P., Ostblom, J.E.E., Lu¨cker, P.B., Shukla, S., Alvarez,
M.M., Oh, S.K.W., Yin, T., and Zandstra, P.W. (2013). High-
throughput fingerprinting of human pluripotent stem cell fate re-
sponses and lineage bias. Nat. Methods 10, 1225–1231.
Nihongaki, Y., Kawano, F., Nakajima, T., and Sato, M. (2015). Pho-
toactivatable CRISPR-Cas9 for optogenetic genome editing. Nat.
Biotechnol. 33, 755–760.
Nissim, L., Perli, S.D., Fridkin, A., Perez-Pinera, P., and Lu, T.K.
(2014). Multiplexed and programmable regulation of gene net-120 Stem Cell Reports j Vol. 6 j 109–120 j January 12, 2016 j ª2016 The Autworks with an integrated RNA and CRISPR/Cas toolkit in human
cells. Mol. Cell 54, 698–710.
Sanjana, N.E., Shalem, O., and Zhang, F. (2014). Improved vectors
and genome-wide libraries for CRISPR screening. Nat. Methods 11,
783–784.
Schumann, K., Lin, S., Boyer, E., Simeonov, D.R., Subramaniam,
M., Gate, R.E., Haliburton, G.E., Ye, C.J., Bluestone, J.A., Doudna,
J.A., and Marson, A. (2015). Generation of knock-in primary hu-
man T cells using Cas9 ribonucleoproteins. Proc. Natl. Acad. Sci.
USA 112, 10437–10442.
Sha, J., Lippmann, E.S., McNulty, J., Ma, Y., and Ashton, R.S.
(2013). Sequential nucleophilic substitutions permit orthogonal
click functionalization of multicomponent PEG brushes. Bio-
macromolecules 14, 3294–3303.
Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mik-
kelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G., and
Zhang, F. (2014). Genome-scale CRISPR-Cas9 knockout screening
in human cells. Science 343, 84–87.
Shechner, D.M., Hacisuleyman, E., Younger, S.T., and Rinn, J.L.
(2015). Multiplexable, locus-specific targeting of long RNAs with
CRISPR-Display. Nat. Methods 12, 664–670.
Shi, J., Wang, E., Milazzo, J.P., Wang, Z., Kinney, J.B., and Vakoc,
C.R. (2015). Discovery of cancer drug targets by CRISPR-Cas9
screening of protein domains. Nat. Biotechnol. 33, 661–667.
Singh, S., Carpenter, A.E., andGenovesio, A. (2014). Increasing the
content of high-content screening an overview. J. Biomol. Screen
19, 640–650.
Smurnyy, Y., Cai, M., Wu, H., McWhinnie, E., Tallarico, J.A., Yang,
Y., and Feng, Y. (2014). DNA sequencing andCRISPR-Cas9 gene ed-
iting for target validation inmammalian cells. Nat. Chem. Biol. 10,
623–625.
Sternberg, S.H., andDoudna, J.A. (2015). Expanding the biologist’s
toolkit with CRISPR-Cas9. Mol. Cell 58, 568–574.
Taylor, D.L., and Haskins, J.R. (2007). High Content Screening:
A Powerful Approach to Systems Cell Biology and Drug Discovery
(Springer Science & Business Media).
Wang, T., Wei, J.J., Sabatini, D.M., and Lander, E.S. (2014). Genetic
screens in human cells using theCRISPR-Cas9 system. Science 343,
80–84.
Xu, H., Xiao, T., Chen, C.-H., Li, W., Meyer, C., Wu, Q., Wu, D.,
Cong, L., Zhang, F., Liu, J.S., et al. (2015). Sequence determinants
of improved CRISPR sgRNA design. Genome Res. 25, 1147–1157.
Yang, L., Guell, M., Byrne, S., Yang, J.L., Angeles, A.D.L., Mali, P.,
Aach, J., Kim-Kiselak, C., Briggs, A.W., Rios, X., et al. (2013). Opti-
mization of scarless human stem cell genome editing. Nucleic
Acids Res. 41, 9049–9061.
Zetsche, B., Volz, S.E., and Zhang, F. (2015). A split-Cas9 architec-
ture for inducible genome editing and transcription modulation.
Nat. Biotechnol. 33, 139–142.
Zuris, J.A., Thompson, D.B., Shu, Y., Guilinger, J.P., Bessen, J.L., Hu,
J.H., Maeder, M.L., Joung, J.K., Chen, Z.-Y., and Liu, D.R. (2015).
Cationic lipid-mediated delivery of proteins enables efficient pro-
tein-based genome editing in vitro and in vivo. Nat. Biotechnol.
33, 73–80.hors
